Newark, United States
Ziosoft is a renowned leader in advanced visualization and analytic software, boasting over 2000 installed systems worldwide. The company's flagship product, the Ziostation system, leverages PhyZiodynamic supercomputing to deliver high-fidelity image quality, enabling clinicians to expedite and confidently make diagnoses. Notably, Ziosoft has obtained regulatory clearances for various applications such as CT vessel analysis, CT perfusion, colon analysis, and cardiac function analysis for both MR and CT, all of which are developed organically without reliance on 3rd-party add-on modules.
Based in Newark, California USA and Tokyo, Japan, Ziosoft's solutions are open-standard based, ensuring compatibility with any DICOM imaging modality. The flexibility extends to remote access by multiple concurrent users through a single server without proprietary hardware or 3rd-party virtualization components.
Established in 1998, Ziosoft operates in the Analytics and Health Care industries, focusing on advancing visualization with AI. While details about their last investment and investors are currently undisclosed, the company's track record and innovative approach position it as an intriguing prospect for potential venture capital interest.
